4-Pyridoxic acid

From NuGOwiki

(Redirected from HMDB00017)
Jump to: navigation, search

The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB

Taxonomy Navigation Box; search by

All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein

4-Pyridoxic acid
2D structure for 4-Pyridoxic acid
Chemical Name 3-hydroxy-5-(hydroxymethyl)-2-methyl-pyridine-4-carboxylic acid
Chemical Formula C8H9NO4
CAS Number 82-82-6
Chemical Information HMDB00017
Biochemical Taxonomy

  • Pyridoxals and Derivatives

Functional Taxonomy Not Available
Nutritional Taxonomy Not Available
Metabolic Pathways

  • Nicotinate and Nicotinamide Metabolism
  • Valine, Leucine and Isoleucine Degradation
  • Vitamin B6 Metabolism

Biofluid Location

  • Blood
  • Urine

Tissue Location

  • Erythrocyte
  • Kidney
  • Liver
  • Bladder

Normal Biofluid Concentrations

  • Blood: 0.0071 +/- 0.005 uM
  • Blood: 0.0097 +/- 0.00665 uM
  • Blood: 0.027 (0.0062-3.14) umol/L
  • Blood: 0.040 +/- 0.007 uM
  • Urine: 12.52 +/- 6.53 umol/mmol creatinine
  • Urine: > 3.0 uM

Normal Tissue Concentrations Not Available
Diseases / Conditions Related to Nutrition Not Available
Other (Monogenic Disorders) Not Available
Abnormal Biofluid Concentrations Not Available
Abnormal Tissue Concentrations Not Available
Physiological Processes Not Available
Authors:
Affiliations:

Contents

Introduction

guidelines
The catabolic product of vitamin B6 (pyridoxine, pyridoxal and pyradoxamine) which is excreted in the urine. Urine levels of 4-pyridoxic acid are lower in females than in males and will be reduced in persons with riboflavin deficiency.

Biological Function

guidelines

Catabolism

guidelines

Diseases / Conditions Related to Nutrition

guidelines


Other (Monogenic) Disorders

guidelines


Nutritional Information

guidelines

Drivers for biological variation

guidelines

Vulnerable groups

guidelines

Other resources

guidelines

Links

guidelines